Compounds > oxymatrine
Page last updated: 2024-09-02

oxymatrine and Colorectal Neoplasms

oxymatrine has been researched along with Colorectal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Cai, Z; Huang, J; Li, M; Li, S; Liang, L; Ruan, H; Sun, W; Wang, L; Wei, X; Zhang, J; Zhao, B1
Ban, D; Gu, M; Hua, S; Ji, H; Wang, Y1
Jiang, Y; Liu, L; Wang, J; Xiong, Y; Zhu, H1
Huang, J; Liang, L1
Fan, Y; Liu, C; Wang, J; Wang, X; Wang, Y; Wang, Z1

Other Studies

5 other study(ies) available for oxymatrine and Colorectal Neoplasms

ArticleYear
Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:8

    Topics: Alkaloids; Animals; Colorectal Neoplasms; Humans; Inflammasomes; Liver Neoplasms; Mice; Mitophagy; NLR Family, Pyrin Domain-Containing 3 Protein

2023
Oxymatrine reduces expression of programmed death-ligand 1 by promoting DNA demethylation in colorectal cancer cells.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:4

    Topics: Alkaloids; Azacitidine; B7-H1 Antigen; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; DNA Demethylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; HCT116 Cells; Humans; Immune Checkpoint Inhibitors; Interferon-gamma; Quinolizines; RNA, Messenger

2021
Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Oncology reports, 2018, Volume: 39, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Alkaloids; Antigens, CD; Antiviral Agents; Apoptosis; Biomarkers, Tumor; Cadherins; Case-Control Studies; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Prognosis; Quinolizines; RNA, Long Noncoding; Survival Rate; Tumor Cells, Cultured

2018
Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-κB signaling in colorectal cancer cells.
    Oncology reports, 2016, Volume: 36, Issue:3

    Topics: Alkaloids; Biomarkers, Tumor; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Neoplasm Invasiveness; NF-kappa B; Quinolizines; Signal Transduction; Snail Family Transcription Factors

2016
Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.
    Oncology reports, 2017, Volume: 37, Issue:2

    Topics: Alkaloids; Antiviral Agents; Apoptosis; Blotting, Western; Cadherins; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Humans; p38 Mitogen-Activated Protein Kinases; Plasminogen Activator Inhibitor 1; Quinolizines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Tumor Cells, Cultured; Wound Healing

2017